Cite
HARVARD Citation
Ngoi, N. et al. (n.d.). DNA Damage Response (DDR) Basket of Baskets (D-BOB) Trial: Phase 1/2 Study of the ATR inhibitor (ATRi) berzosertib and PD-L1 inhibitor avelumab in patients (pts) with advanced solid tumors with DDR molecular alterations. European journal of cancer. pp. S10-. [Online].